643 related articles for article (PubMed ID: 15181656)
21. [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment].
Iglesias Garcia C; Santamarina Montila S; Alonso Villa MJ
Actas Esp Psiquiatr; 2006; 34(4):277-9. PubMed ID: 16823689
[TBL] [Abstract][Full Text] [Related]
22. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
23. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
[TBL] [Abstract][Full Text] [Related]
24. A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia.
Arango C; Gómez-Beneyto M; Brenlla J; Gastó C; Sarramea-Crespo F; Chamorro L; Masramon X; Díez T;
Eur Neuropsychopharmacol; 2007; 17(6-7):456-63. PubMed ID: 17234389
[TBL] [Abstract][Full Text] [Related]
25. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis.
Lieberman JA
J Clin Psychiatry; 1996; 57 Suppl 11():68-71. PubMed ID: 8941173
[TBL] [Abstract][Full Text] [Related]
26. Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.
Chan J; Sweeting M
J Psychopharmacol; 2007 Aug; 21(6):657-64. PubMed ID: 17092976
[TBL] [Abstract][Full Text] [Related]
27. Successful switch from clozapine to aripiprazole: a case report.
Jong-Yih L
J Clin Psychopharmacol; 2009 Feb; 29(1):93-5. PubMed ID: 19142120
[No Abstract] [Full Text] [Related]
28. [Social cognition and atypical antipsychotic agents in the treatment of persons with schizophrenia: preliminary data from a naturalistic study].
Mazza M; Tozzini C; Giosué P; De Risio A; Palmucci M; Roncone R; Casacchia M
Clin Ter; 2003; 154(2):79-83. PubMed ID: 12856365
[TBL] [Abstract][Full Text] [Related]
29. Clozapine and ziprasidone: a useful combination in patients with treatment-resistant schizophrenia.
Ziegenbein M; Calliess IT
J Neuropsychiatry Clin Neurosci; 2006; 18(2):246-7. PubMed ID: 16720806
[No Abstract] [Full Text] [Related]
30. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
31. Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.
Sacchetti E; Galluzzo A; Valsecchi P; Romeo F; Gorini B; Warrington L;
Schizophr Res; 2009 May; 110(1-3):80-9. PubMed ID: 19269791
[TBL] [Abstract][Full Text] [Related]
32. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.
Munro J; Matthiasson P; Osborne S; Travis M; Purcell S; Cobb AM; Launer M; Beer MD; Kerwin R
Acta Psychiatr Scand; 2004 Oct; 110(4):292-8. PubMed ID: 15352931
[TBL] [Abstract][Full Text] [Related]
33. [The chances of new atypical substances].
Falkai P; Vogeley K
Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S32-7. PubMed ID: 10907611
[TBL] [Abstract][Full Text] [Related]
34. Ziprasidone augmentation of clozapine in 11 patients.
Kaye NS
J Clin Psychiatry; 2003 Feb; 64(2):215-6. PubMed ID: 12633133
[No Abstract] [Full Text] [Related]
35. Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia.
Bhatia SC; Bhatia SK; Gupta S
J ECT; 1998 Dec; 14(4):280-3. PubMed ID: 9871852
[TBL] [Abstract][Full Text] [Related]
36. Strategies for successful clinical management of schizophrenia with ziprasidone.
Fagiolini A; Cañas F; Gallhofer B; Larmo I; Levy P; Montes JM; Papageorgiou G; Zink M; Rossi A
Expert Opin Pharmacother; 2010 Sep; 11(13):2199-220. PubMed ID: 20658947
[TBL] [Abstract][Full Text] [Related]
37. A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia.
Doruk A; Uzun O; Ozşahin A
Int Clin Psychopharmacol; 2008 Jul; 23(4):223-7. PubMed ID: 18545061
[TBL] [Abstract][Full Text] [Related]
38. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
[TBL] [Abstract][Full Text] [Related]
39. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
Cipriani A; Boso M; Barbui C
Cochrane Database Syst Rev; 2009 Jul; (3):CD006324. PubMed ID: 19588385
[TBL] [Abstract][Full Text] [Related]
40. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
Croissant B; Hermann D; Olbrich R
Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
